UnknownNot Applicable

ALT Routinely Recorded Remotely: A Comparator Study of Liver Function Tests Using the Tasso+ to Venipuncture.

United States80 participantsStarted 2021-02-16

Plain-language summary

A direct comparison study of blood samples collected using the Tasso+ device and venous blood samples in patients with elevated alanine transaminase (ALT).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subject must be willing and able to provide written informed consent prior to study entry
✓. Subject is ≥ 18 years of age.
✓. Subject must meet the following criterion:
✓. Subject must be willing and able to adhere to the assessments, study schedule, prohibitions and restrictions as described in the protocol.
✓. Patients may be on any treatment / therapeutic clinical trial as indicated by treating physician

Exclusion criteria

✕. Pregnant or nursing female by self-report.
✕. Presents with abnormal skin integrity or atypical skin health within the areas to be tested (upper shoulders).
✕. Subjects who have applied lotion to the skin on the shoulder the day of the visit.
✕. Patients with hepatic encephalopathy
✕. Vulnerable populations (children, prisoners, pregnant women, participants with diminished decision-making capacity, illiterate populations, educationally disadvantaged populations).

What they're measuring

Venous and Tasso+ blood sample comparison for ALT

Timeframe: through study completion, an average of 1 Year and 6 Months

Trial details

NCT IDNCT05259618

SponsorTasso Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2022-11

Contact for this trial

Brook Quist

(206) 822-4186 brook@tassoinc.com

View on ClinicalTrials.gov More Elevated Alanine Transaminase (ALT) trials